Pharma Deals Review, Vol 2005, No 58 (2005)

Font Size:  Small  Medium  Large

Osei Acquires Exclusive Rights to Bacterial Therapeutic from Miyarisan

Business Review Editor

Abstract


Osei entered into a licensing deal with Miyarisan. Pursuant to terms of the agreement, Osei has obtained the exclusive rights to commercialize Miyarisan’s probiotic - MIYA-BM® in North America and Europe.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.